Purpose: The purpose of this research is to investigate the relationship between institutional investor inattention, accruals quality and conditional conservatism. Methodology: This research is applied and correlational.
Mohamad Mohamadi +1 more
doaj
Retinopathy of prematurity screening program for government neonatal intensive care units by a non-profit tertiary eye care center in India: A collaborative public health initiative. [PDF]
Singh S, Agarwal M, Sabherwal S.
europepmc +1 more source
Diabetes Research and Resource Sharing During the COVID-19 Pandemic: A Systematic Review and Experience from an Academic/Non-Profit Resource Website. [PDF]
Yeung AM +13 more
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Unlocking potential: innovative "private-non-profit" partnership for empowering children with disabilities in resource-limited settings in Nepal. [PDF]
Banskota B +4 more
europepmc +1 more source
Editorial: Management of Intangible Assets Among Non-profit Organizations: Challenges and Peculiarities. [PDF]
Benevene P +5 more
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Job Demands and Resources, Burnout, and Psychological Distress of Employees in the Chinese Non-profit Sector. [PDF]
Deng G, Huang C, Cheung SP, Zhang C.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Oocyte donors' experience and expectations in a non-profit fertility care setting. [PDF]
Li Piani L +7 more
europepmc +1 more source

